Folgen
Georg Andreas Schett
Georg Andreas Schett
FAU Erlangen-Nürnberg
Bestätigte E-Mail-Adresse bei uk-erlangen.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
The pathogenesis of rheumatoid arthritis
IB McInnes, G Schett
New England Journal of Medicine 365 (23), 2205-2219, 2011
62432011
Cytokines in the pathogenesis of rheumatoid arthritis
IB McInnes, G Schett
Nature Reviews Immunology 7 (6), 429-442, 2007
31072007
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Emerging Risk Factors Collaboration
The Lancet 375 (9709), 132-140, 2010
27302010
Dickkopf-1 is a master regulator of joint remodeling
D Diarra, M Stolina, K Polzer, J Zwerina, MS Ominsky, D Dwyer, A Korb, ...
Nature medicine 13 (2), 156-163, 2007
16182007
Trial of tocilizumab in giant-cell arteritis
JH Stone, K Tuckwell, S Dimonaco, M Klearman, M Aringer, D Blockmans, ...
New England Journal of Medicine 377 (4), 317-328, 2017
12452017
Pathogenetic insights from the treatment of rheumatoid arthritis
IB McInnes, G Schett
The Lancet 389 (10086), 2328-2337, 2017
11792017
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
L Gossec, JS Smolen, S Ramiro, M De Wit, M Cutolo, M Dougados, ...
Annals of the rheumatic diseases 75 (3), 499-510, 2016
11332016
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
G Schett, E Gravallese
Nature Reviews Rheumatology 8 (11), 656-664, 2012
9432012
Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines
C Schauer, C Janko, LE Munoz, Y Zhao, D Kienhöfer, B Frey, M Lell, ...
Nature medicine 20 (5), 511-517, 2014
9092014
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
L Gossec, X Baraliakos, A Kerschbaumer, M de Wit, I McInnes, ...
Annals of the rheumatic diseases 79 (6), 700-712, 2020
8762020
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
A Akhmetshina, K Palumbo, C Dees, C Bergmann, P Venalis, P Zerr, ...
Nature communications 3 (1), 735, 2012
8572012
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
U Harre, D Georgess, H Bang, A Bozec, R Axmann, E Ossipova, ...
The Journal of clinical investigation 122 (5), 1791-1802, 2012
8462012
Osteoclasts are essential for TNF-α–mediated joint destruction
K Redlich, S Hayer, R Ricci, JP David, M Tohidast-Akrad, G Kollias, ...
The Journal of clinical investigation 110 (10), 1419-1427, 2002
7492002
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
S Kiechl, G Schett, G Wenning, K Redlich, M Oberhollenzer, A Mayr, ...
Circulation 109 (18), 2175-2180, 2004
7122004
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
V Urbonaviciute, BG Fürnrohr, S Meister, L Munoz, P Heyder, ...
The Journal of experimental medicine 205 (13), 3007-3018, 2008
6322008
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
D Schramek, A Leibbrandt, V Sigl, L Kenner, JA Pospisilik, HJ Lee, ...
Nature 468 (7320), 98-102, 2010
6302010
EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice
P Mandl, V Navarro-Compán, L Terslev, P Aegerter, D Van Der Heijde, ...
Annals of the rheumatic diseases 74 (7), 1327-1339, 2015
5992015
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
RB Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, ...
Cell Death & Differentiation 23 (6), 962-978, 2016
5972016
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
A Kavanaugh, PJ Mease, JJ Gomez-Reino, AO Adebajo, J Wollenhaupt, ...
Annals of the rheumatic diseases 73 (6), 1020-1026, 2014
5422014
Is atherosclerosis an immunologically mediated disease?
G Wick, G Schett, A Amberger, R Kleindienst, Q Xu
Immunology today 16 (1), 27-33, 1995
5241995
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20